White House backs off ‘backdoor rebate’ idea for lowering drug prices

Published July 11, 2019 12:42pm ET



The White House has thrown out a plan to upend the drug pricing rebate model that President Trump’s health chief once said could be the “most significant change” in how medicines are priced.

Judd Deere, White House spokesman, said that the idea was pulled by Trump “based on careful analysis and thorough consideration.”

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.